Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Experimentally Induced Hot Flashes on Sleep and Mood
NCT01116401Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2009
- Primary completion
- Dec 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of leuprolide, sponsored by Massachusetts General Hospital. Primary endpoint: Wake After Sleep Onset at 4 weeks. Started Nov 2009; status: completed.
02
Drugs
leuprolide
Beyond the preview
Go deeper on NCT01116401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116401.